Skip to main content
News

Taiga Biotechnologies important milestone

Taiga Biotechnologies important milestone

Reaching a
milestone

Optimapharm is pleased to announce we have reached an important milestone on Taiga Biotechnologies Inc. TBX-2400-01 study initiating first site in Croatia for patients undergoing hematopoietic stem cell transplant (HSCT).

#teamOptimapharm is excited for continuation of collaboration with Taiga Biotechnologies and proud to support them in the fight against blood cancers.

Read the full article at: https://www.prnewswire.com/news-releases/taiga-initiates-phase-12-clinical-study-of-tbx-2400-in-acute-myeloid-leukemia-and-myelofibrosis-in-croatia-301420845.html

For more information about clinical trial please visit: https://clinicaltrials.gov/ct2/show/NCT04709458?term=taiga+biotechnologies&draw=2&rank=1

“I wanted to say thank you for your superb support and collaboration this year. I am looking forward to work with you in 2019 as it is a pleasure to work with you and your team.”

Senior Manager Partner

Let’s talk about your pharma study needs

REQUEST PROPOSAL
“

I would like to thank you all for the tremendous work done to reach this important milestone for the study in a very challenging and complex global environment. It is the first of many others that we will have to achieve together. Let's keep it up!

Clinical Project Leader, Big Pharma Company
“

We are very grateful for your hard work and dedication over the past few years. We are delighted to be part of this partnership and look forward to start treating patients in this new therapeutic area soon. We could not have done this without your contribution. We are very excited about the path ahead and can hardly wait to start this study.

Chief Executive Officer, Biotech Company
“

Corporate team and I would like to sincerely thank all the team members, both global and local, as well as the site staff, who have worked extremely hard to reach this lock! This has been achieved under difficult circumstances, being significantly earlier than planned for this discontinued study and in the middle of the COVID-19 pandemic with lockdowns or curfews in place in many of the countries. A huge thank you to all for your team spirit and commitment to reach this goal!

Clinical Project Lead, Big Pharma Company
“

Very pleased. Looking forward to getting the country up and running soon.

VP Global Clinical Operations, Medical Device Company

Let's talk about your study needs 

REQUEST PROPOSAL
Privacy policy »
Online privacy policy »
GDPR information »
Cookie policy »
Corporate information »
Head Office
Almeria Business Tower
Ulica grada Vukovara 284
10000 Zagreb, Croatia
T: +385-1-560 3600
© 2023 Optimapharm.
All rights reserved
Interested in a career with us?
View current opportunities »

 

Connect with us »
Optimapharm